Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
East Asian Arch Psychiatry ; 34(2): 23-28, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38955787

RÉSUMÉ

BACKGROUND: There is evidence suggesting that autistic traits are associated with schizotypal traits. This study examined the factor structure of the Autism Spectrum Quotient 10 (AQ-10) and its associations with schizotypal traits (measured by the Schizotypal Personality Questionnaire-Brief [SPQ-B]) in a cohort of Chinese adolescents and young adults. METHODS: Invitation letters, stratified by locations and housing types, were randomly sent to individuals aged 15 to 24 years for participation. Assessments were made using face-to-face or online interviews. Autistic traits were assessed using the Chinese version of the AQ-10. Schizotypal personality traits were assessed using the Chinese version of the 22-item SPQ-B. RESULTS: In total, 395 male and 536 female participants (mean age, 19.93 years) were recruited between July 2020 and May 2021. Exploratory factor analysis of the AQ-10 yielded three factors (theory of mind, task switching, and attention deficits) explaining 55.11% of the total variance. Autistic traits were positively correlated with schizotypal traits of disorganised features (r = 0.21, p < 0.001), interpersonal relationship deficits (r = 0.19, p < 0.001), and cognitive-perceptual deficits (r = 0.11, p = 0.001). CONCLUSION: In Chinese adolescents and young adults, autistic traits, especially task switching and attention deficits (compared with theory of mind) are more closely correlated with schizotypal personality traits. Disentangling the overlapping and diametrical structure of autistic traits and schizotypal traits may help understand their aetiologies, assessment, and interventions.


Sujet(s)
Trouble du spectre autistique , Trouble de la personnalité schizotypique , Humains , Mâle , Femelle , Adolescent , Jeune adulte , Trouble de la personnalité schizotypique/psychologie , Trouble du spectre autistique/psychologie , Hong Kong , Analyse statistique factorielle , Enquêtes et questionnaires , Adulte , Théorie de l'esprit , Échelles d'évaluation en psychiatrie
2.
Nature ; 625(7996): 760-767, 2024 Jan.
Article de Anglais | MEDLINE | ID: mdl-38092039

RÉSUMÉ

GDF15, a hormone acting on the brainstem, has been implicated in the nausea and vomiting of pregnancy, including its most severe form, hyperemesis gravidarum (HG), but a full mechanistic understanding is lacking1-4. Here we report that fetal production of GDF15 and maternal sensitivity to it both contribute substantially to the risk of HG. We confirmed that higher GDF15 levels in maternal blood are associated with vomiting in pregnancy and HG. Using mass spectrometry to detect a naturally labelled GDF15 variant, we demonstrate that the vast majority of GDF15 in the maternal plasma is derived from the feto-placental unit. By studying carriers of rare and common genetic variants, we found that low levels of GDF15 in the non-pregnant state increase the risk of developing HG. Conversely, women with ß-thalassaemia, a condition in which GDF15 levels are chronically high5, report very low levels of nausea and vomiting of pregnancy. In mice, the acute food intake response to a bolus of GDF15 is influenced bi-directionally by prior levels of circulating GDF15 in a manner suggesting that this system is susceptible to desensitization. Our findings support a putative causal role for fetally derived GDF15 in the nausea and vomiting of human pregnancy, with maternal sensitivity, at least partly determined by prepregnancy exposure to the hormone, being a major influence on its severity. They also suggest mechanism-based approaches to the treatment and prevention of HG.


Sujet(s)
Facteur-15 de croissance et de différenciation , Hyperémèse gravidique , Nausée , Vomissement , Animaux , Femelle , Humains , Souris , Grossesse , bêta-Thalassémie/sang , bêta-Thalassémie/métabolisme , Foetus/métabolisme , Facteur-15 de croissance et de différenciation/sang , Facteur-15 de croissance et de différenciation/métabolisme , Hormones/sang , Hormones/métabolisme , Hyperémèse gravidique/complications , Hyperémèse gravidique/métabolisme , Hyperémèse gravidique/prévention et contrôle , Hyperémèse gravidique/thérapie , Nausée/sang , Nausée/complications , Nausée/métabolisme , Placenta/métabolisme , Vomissement/sang , Vomissement/complications , Vomissement/métabolisme
3.
Nature ; 599(7885): 436-441, 2021 11.
Article de Anglais | MEDLINE | ID: mdl-34732894

RÉSUMÉ

The state of somatic energy stores in metazoans is communicated to the brain, which regulates key aspects of behaviour, growth, nutrient partitioning and development1. The central melanocortin system acts through melanocortin 4 receptor (MC4R) to control appetite, food intake and energy expenditure2. Here we present evidence that MC3R regulates the timing of sexual maturation, the rate of linear growth and the accrual of lean mass, which are all energy-sensitive processes. We found that humans who carry loss-of-function mutations in MC3R, including a rare homozygote individual, have a later onset of puberty. Consistent with previous findings in mice, they also had reduced linear growth, lean mass and circulating levels of IGF1. Mice lacking Mc3r had delayed sexual maturation and an insensitivity of reproductive cycle length to nutritional perturbation. The expression of Mc3r is enriched in hypothalamic neurons that control reproduction and growth, and expression increases during postnatal development in a manner that is consistent with a role in the regulation of sexual maturation. These findings suggest a bifurcating model of nutrient sensing by the central melanocortin pathway with signalling through MC4R controlling the acquisition and retention of calories, whereas signalling through MC3R primarily regulates the disposition of calories into growth, lean mass and the timing of sexual maturation.


Sujet(s)
Développement de l'enfant/physiologie , État nutritionnel/physiologie , Puberté/physiologie , Récepteur de la mélanocortine de type 3/métabolisme , Maturation sexuelle/physiologie , Adolescent , Sujet âgé de 80 ans ou plus , Animaux , Enfant , Cycle oestral/génétique , Cycle oestral/physiologie , Femelle , Homozygote , Humains , Hypothalamus/cytologie , Hypothalamus/physiologie , Facteur de croissance IGF-I/métabolisme , Mâle , Mélanocortines/métabolisme , Ménarche/génétique , Ménarche/physiologie , Souris , Phénotype , Puberté/génétique , Récepteur de la mélanocortine de type 3/déficit , Récepteur de la mélanocortine de type 3/génétique , Maturation sexuelle/génétique , Facteurs temps , Prise de poids
4.
Transl Psychiatry ; 5: e669, 2015 Nov 03.
Article de Anglais | MEDLINE | ID: mdl-26529422

RÉSUMÉ

Prior studies have established that schizotypal personality traits (schizotypy) were associated with antisocial behavior (crime), but it is unclear what neural factors mediate this relationship. This study assessed the mediating effect that sub-regional prefrontal gray, specifically the orbitofrontal gray matter volume, has on the schizotypy-antisocial behavior relationship. Five prefrontal sub-regional (superior, middle, inferior, orbitofrontal and rectal gyral) gray matter volumes were assessed using structural magnetic resonance imaging in 90 adults from the community, together with schizotypy and antisocial behavior. Among all five prefrontal sub-regions, the orbitofrontal cortex (OFC) was the major region-of-interest in the present study. Mediation analyses showed that orbitofrontal gray fully mediated the association between schizotypy and antisocial behavior. After having controlled the sex, age, socio-economic statuses, whole brain volumes and substance abuse/dependence of test subjects, the orbitofrontal gray still significantly mediated the effect of schizotypy on antisocial behavior by 53.5%. These findings are the first that document a neural mediator of the schizotypy-antisocial behavior relationship. Findings also suggest that functions subserved by the OFC, including impulse control and inhibition, emotion processing and decision-making, may contribute to the above comorbidity.


Sujet(s)
Cartographie cérébrale , Imagerie par résonance magnétique , Adulte , Trouble de la personnalité de type antisocial/complications , Trouble de la personnalité de type antisocial/physiopathologie , Encéphale/physiopathologie , Femelle , Humains , Traitement d'image par ordinateur , Mâle , Adulte d'âge moyen , Trouble de la personnalité schizotypique/complications , Trouble de la personnalité schizotypique/physiopathologie , Jeune adulte
5.
J Neuroendocrinol ; 22(8): 915-25, 2010 Aug.
Article de Anglais | MEDLINE | ID: mdl-20553370

RÉSUMÉ

Leptin plays a major role in coordinating the integrated response of the brain to changes in nutritional state. Leptin receptor expressing neurones within the arcuate nucleus (ARC) of the hypothalamus sense circulating leptin and densely innervate other regions of the hypothalamus, including the paraventricular nucleus (PVN). In the ARC, leptin is known to alter the expression of genes with important roles in the control of energy balance, and the aim of the present study was to obtain a more comprehensive picture of the action of leptin in these nuclei. Mice were ad libitum fed, or fasted for 48 h when receiving either sham or i.p. leptin treatment. We used laser capture microdissection and microarrays to identify leptin-regulated transcripts within the ARC. Expression of 639 genes are increased and 452 decreased within the fasted ARC. Leptin regulates 15% and 20% of these genes, respectively. In addition to expected changes in Pomc, Agrp, Npy and Cart, pathway analysis indicated that leptin regulated other genes concerned with energy homeostasis and endocrine function. As previously reported for the PVN, leptin also altered the expression of genes involved in nervous system development and synaptic function. However, aside from a small number of such genes (e.g. Gap43), leptin influenced the expression of different sets of neuronal developmental genes in the ARC and PVN. In conclusion, the present study identifies a set of genes that are regulated, at least in part, by leptin in the ARC, highlighting these as candidates for possible roles in leptin action and resistance.


Sujet(s)
Noyau arqué de l'hypothalamus/physiologie , Jeûne/physiologie , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes , Leptine/métabolisme , Animaux , Mâle , Souris , Analyse sur microréseau , Données de séquences moléculaires
6.
Phytother Res ; 18(7): 525-30, 2004 Jul.
Article de Anglais | MEDLINE | ID: mdl-15305310

RÉSUMÉ

In the 16-week pilot study, the effect of a Yang-promoting Chinese herbal suppository preparation (VI-28) on the red cell antioxidant status was examined in 31 healthy male subjects aged 41-66 years old. VI-28 treatment for 12 weeks (one suppository (0.3 g) daily for week 1-4; one every 2 days for week 5-8; one every 3 days for week 9-12) produced a time/dose-dependent alteration in red cell antioxidant status. The VI-28-induced change is characterized by a slight depletion in cellular reduced glutathione (GSH) level and a decrease in susceptibility to peroxide-induced lipid peroxidation as well as increases in catalase (CAT) and Cu-Zn-superoxide dismutase (SOD) activities. While a reversal trend of change was observed in cellular GSH level, the susceptibility to lipid peroxidation as well as the CAT activity after the cessation of treatment for 4 weeks, the SOD activity exhibited a protracted increase. The results indicate that VI-28 treatment enhances red cell antioxidant status in male subjects. The beneficial effect of VI-28 treatment on red cells may re fl ect a corresponding change in antioxidant status of peripheral tissues.


Sujet(s)
Antioxydants/métabolisme , Médicaments issus de plantes chinoises/pharmacologie , Érythrocytes/effets des médicaments et des substances chimiques , Phytothérapie , Plantes médicinales , Adulte , Sujet âgé , Relation dose-effet des médicaments , Calendrier d'administration des médicaments , Médicaments issus de plantes chinoises/administration et posologie , Médicaments issus de plantes chinoises/usage thérapeutique , Érythrocytes/métabolisme , Humains , Peroxydation lipidique/effets des médicaments et des substances chimiques , Mâle , Adulte d'âge moyen , Projets pilotes , Suppositoires , Déficit du Yang/prévention et contrôle
7.
Phytomedicine ; 10(4): 286-91, 2003 May.
Article de Anglais | MEDLINE | ID: mdl-12809358

RÉSUMÉ

Tanshinones are the major lipid soluble pharmacological constituents of Danshen, the dried roots of Salvia miltiorrhiza Bunge (Labiatae), a well known traditional Chinese medicine used for the treatment of cerebrovascular diseases including stroke. Potential neuroprotective effects of tanshinones IIA (TsIIA) and IIB (TsIIB) were examined in adult mice subjected to transient focal cerebral ischemia caused by middle cerebral artery occlusion (MCAo). Our results revealed that TsIIA (16 mg/kg) readily penetrated the blood brain barrier reaching a peak concentration of 0.41 nmol/g brain wet weight 60 minutes after intraperitoneal injection and decreased slowly over several hours. Twenty-four hours after middle cerebral artery occlusion, brain infarct volume was reduced by 30% and 37% following treatment with TsIIA and TsIIB, respectively. The reduction in brain infarct volume was accompanied by a significant decrease in the observed neurological deficit. Tanshinones or other structurally related compounds may have potential for further development as neuroprotective drugs.


Sujet(s)
Anticoagulants/usage thérapeutique , Encéphalopathie ischémique/traitement médicamenteux , Médicaments issus de plantes chinoises/usage thérapeutique , Phénanthrènes/usage thérapeutique , Phytothérapie , Salvia miltiorrhiza , Abiétanes , Animaux , Anticoagulants/administration et posologie , Anticoagulants/pharmacocinétique , Encéphalopathie ischémique/induit chimiquement , Médicaments issus de plantes chinoises/administration et posologie , Médicaments issus de plantes chinoises/pharmacocinétique , Injections péritoneales , Mâle , Souris , Souris de lignée C57BL , Phénanthrènes/administration et posologie , Phénanthrènes/pharmacocinétique , Extraits de plantes/administration et posologie , Extraits de plantes/pharmacocinétique , Extraits de plantes/usage thérapeutique , Racines de plante
8.
Planta Med ; 68(3): 217-20, 2002 Mar.
Article de Anglais | MEDLINE | ID: mdl-11914957

RÉSUMÉ

Intragastric administration (100-200 micromol/kg) of tacrine (THA) or bis(7)-THA could cause an acute and dose-dependent increase in plasma alanine aminotransferases activity in mice at 6 h after the drug administration. The increase in plasma enzyme activity was associated with an increase in hepatic malondialdehyde level, an indirect index of oxidative tissue damage. Pretreating mice with schisandrin B (Sch B), an active dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, at a daily dose of 0.125-0.5 mmol/kg for 3 days protected against the THA/bis(7)-THA induced hepatic oxidative damage in a dose-dependent manner. Sch B treatment (0.025-0.5 mmol/kg/day x 5) also enhanced the passive avoidance-response in mice as assessed by the step-through task experiment. The ensemble of results suggests that Sch B may be useful for reducing the potential hepatotoxicity of THA/bis(7)-THA in anti-Alzheimer's therapy.


Sujet(s)
Cognition/effets des médicaments et des substances chimiques , Lignanes/pharmacologie , Foie/effets des médicaments et des substances chimiques , Composés polycycliques/pharmacologie , Schisandraceae , Tacrine/analogues et dérivés , Tacrine/toxicité , Alanine transaminase/sang , Alanine transaminase/métabolisme , Animaux , Apprentissage par évitement/effets des médicaments et des substances chimiques , Comportement animal/effets des médicaments et des substances chimiques , Cyclooctanes , Relation dose-effet des médicaments , Fruit/composition chimique , Lignanes/composition chimique , Lignanes/isolement et purification , Mâle , Souris , Souris de lignée ICR , Extraits de plantes/composition chimique , Extraits de plantes/pharmacologie , Composés polycycliques/composition chimique , Composés polycycliques/isolement et purification , alpha-Tocophérol/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE